Cargando…

Treatment of hypercholesterolaemia in older adults calls for a patient-centred approach

Due to an increasing number of older adults with (risk factors for) cardiovascular disease (CVD), the sum of older adults eligible for lipid-lowering drugs will increase. This has risen questions about benefits and harms of lipid-lowering therapy in older adults with a varying number of (cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kleipool, Emma EF, Dorresteijn, Johannes AN, Smulders, Yvo M, Visseren, Frank LJ, Peters, Mike JL, Muller, Majon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027025/ https://www.ncbi.nlm.nih.gov/pubmed/31780523 http://dx.doi.org/10.1136/heartjnl-2019-315600

Ejemplares similares

Managing older patients with heart failure calls for a holistic approach
por: Wiersinga, Julia H.I., et al.
Publicado: (2021)

Frailty in Older Adults with Cardiovascular Disease: Cause, Effect or Both?
por: Kleipool, Emma EF., et al.
Publicado: (2018)

The relevance of a multidomain geriatric assessment in older patients with heart failure
por: Kleipool, Emma E.F., et al.
Publicado: (2020)

Orthostatic Hypotension: An Important Risk Factor for Clinical Progression to Mild Cognitive Impairment or Dementia. The Amsterdam Dementia Cohort
por: Kleipool, Emma E.F., et al.
Publicado: (2019)

Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia
por: Visseren, F. L. J.
Publicado: (2011)

Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency department
por: van Dam, Carmen S., et al.
Publicado: (2022)

The potential harm of oxygen therapy in medical emergencies
por: Cornet, Alexander D, et al.
Publicado: (2013)

Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives
por: Jaspers, Nicole E M, et al.
Publicado: (2018)

Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial
por: Jaspers, Nicole E M, et al.
Publicado: (2021)

Hypercholesterolaemia in a vegan.
por: Duggan, B., et al.
Publicado: (1997)

Nutraceuticals in hypercholesterolaemia: an overview
por: Santini, Antonello, et al.
Publicado: (2016)

The genetics and screening of familial hypercholesterolaemia
por: Henderson, Raymond, et al.
Publicado: (2016)

Genetic Architecture of Familial Hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

Tendon xanthomas in familial hypercholesterolaemia
por: Bharath, Gopinath, et al.
Publicado: (2020)

Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
por: de Vries, Tamar Irene, et al.
Publicado: (2021)

Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK
por: Kerr, Marion, et al.
Publicado: (2017)

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
por: Stam‐Slob, Manon C., et al.
Publicado: (2017)

Hypercholesterolaemia – practical information for non-specialists
por: Soran, Handrean, et al.
Publicado: (2017)

Cardiovascular risk stratification in familial hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2016)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Prevalence of cardiovascular events in genetically confirmed versus unconfirmed familial hypercholesterolaemia
por: Khan, Tina Z, et al.
Publicado: (2020)

Hypercholesterolaemia: optimal treatment by next-generation drugs?
por: van der Wall, E.E.
Publicado: (2015)

Familial hypercholesterolaemia: cholesterol efflux and coronary disease
por: Versmissen, Jorie, et al.
Publicado: (2016)

Management of homozygous familial hypercholesterolaemia in two brothers
por: Real, José, et al.
Publicado: (2018)

Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Dietary intervention for children and adolescents with familial hypercholesterolaemia
por: Capra, Maria Elena, et al.
Publicado: (2023)

The daily 10 kcal expenditure deficit: a before-and-after study on low-cost interventions in the work environment
por: Dorresteijn, Johannes A N, et al.
Publicado: (2013)

Pharmacological and non-pharmacological interventions to influence adipose tissue function
por: Westerink, Jan, et al.
Publicado: (2011)

Is HbA1c a good diagnostic test for (pre)diabetes in cardiac rehabilitation patients?
por: Smulders, Yvo, et al.
Publicado: (2018)

Controversial role of plant sterol esters in the management of hypercholesterolaemia
por: Weingärtner, Oliver, et al.
Publicado: (2009)

A perspective for sequencing familial hypercholesterolaemia in African Americans
por: Wright, Michelle L, et al.
Publicado: (2016)

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia
por: Dias, Irundika H.K., et al.
Publicado: (2018)

Tendon pathology in hypercholesterolaemia patients: Epidemiology, pathogenesis and management
por: Yang, Yang, et al.
Publicado: (2018)

Paradox of hypercholesterolaemia in highly trained, keto-adapted athletes
por: Creighton, Brent C, et al.
Publicado: (2018)

Hypercholesterolaemia increases the risk of high-turnover osteoporosis in men
por: Zhou, Yanman, et al.
Publicado: (2019)

The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data
por: Ramaswami, Uma, et al.
Publicado: (2017)

Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone
por: Diamond, David M, et al.
Publicado: (2021)

Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care
por: Akyea, Ralph K., et al.
Publicado: (2020)

Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects
por: Blom, Henk J., et al.
Publicado: (2010)

The role of guidelines and the patient's life-style in GPs' management of hypercholesterolaemia
por: Backlund, Lars, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_ur4rdv259nt9cie1svflejocps